Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

13.47
Delayed Data
As of Apr 17
 -0.02 / -0.15%
Today’s Change
7.09
Today|||52-Week Range
13.68
+62.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues803.0K1.5M12.0M122.0M
 
 
 
 
 
Cost of Goods Sold29.7M--362.0K4.8M
 
 
 
 
Depreciation And Amortization879.0K871.0K742.0K928.0K
 
 
 
 
 
 
Operating ExpensesGross Income-29.8M--10.9M116.3M
 
 
 
 
General Expenses7.9M42.8M72.8M92.1M
 
 
 
 
 
Research And Development--23.5M17.2M19.6M
 
 
 
 
Total Operating Expenses38.6M43.6M73.9M97.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-37.8M-42.2M-61.9M24.2M
 
 
 
 
 
Extraordinary Credit0.000.000.002.8M
 
 
Extraordinary Charge0.000.00-22.9M-2.6M
 
 
 
Interest Expense On Debt1.9M3.6M7.8M5.0M
 
 
 
 
 
Other Expenses117.0K-660.0K101.0K39.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.5M-46.3M-92.3M19.9M
 
 
 
 
 
Income Taxes-16.2M0.000.000.00
 
 
Preferred Dividend-3.4M-1.1M0.000.00
 
 
 
Discontinued Operations2.2M0.000.000.00
 
 
Extraordinary Items74.9M0.000.000.00
 
 
Net Income-21.0M-46.3M-92.3M19.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.9M17.4M31.8M42.3M
 
 
 
 
 
Shares To Calculate EPS Diluted23.9M17.4M31.8M50.6M
 
 
 
 
 
 
Earnings Per ShareEPS$31.39-$2.72-$2.90$0.32
 
 
 
 
 
EPS Diluted-$1.02-$2.72-$2.90$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account